From REPORT ON ACTIVITIES FOR THE QUARTER ENDED 31 MARCH 2024:
"...The Company understands the high level of interest of shareholders in the outcomes of the completedclinical trials. Trials such as BIT225-011 that include longitudinal analyses of a multitude ofimmunological markers involve complex, time-consuming modeling and consultation with relevantexperts. Good progress is being made and the Company looks forward to reporting results duringthe second quarter of 2024...."
There was no specific reference to preliminary or final results, so I guess they have successfully ticked the box by reporting prelims.
- Forums
- ASX - By Stock
- BIT
- The Final Countdown
The Final Countdown, page-91
-
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.002(5.26%) |
Mkt cap ! $36.09M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.9¢ | $4.117K | 105.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 227908 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 184911 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 227908 | 0.038 |
3 | 443512 | 0.037 |
5 | 388512 | 0.036 |
6 | 753214 | 0.035 |
4 | 646000 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 184911 | 2 |
0.041 | 230121 | 4 |
0.042 | 117600 | 1 |
0.043 | 102000 | 1 |
0.044 | 140000 | 1 |
Last trade - 10.45am 03/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online